29699479|t|Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer's disease mice.
29699479|a|BACKGROUND: There is increasing interest in whether anesthetic agents affect the risk or progression of Alzheimer's disease (AD). To mitigate many of the methodological issues encountered in human retrospective cohort studies we have used a transgenic model of AD to investigate the effect of propofol on AD pathology. METHODS: Six month-old amyloid precursor protein/presenilin 1 (APP/PS1) transgenic AD mice and control mice were exposed to 3 doses of propofol (200 mg/kg) or vehicle, delivered at monthly intervals. RESULTS: There was no difference in the extent of beta-amyloid (Abeta) immunolabeled plaque deposition in APP/PS1 mice in vehicle versus propofol treatment groups. We also detected no difference in plaque-associated synapse loss in APP/PS1 mice following repeat propofol exposure relative to vehicle. Western blotting indicated that there was no difference in post-synaptic density protein 95, synaptophysin or glutamic acid decarboxylase 65/67 expression in control or APP/PS1 mice subjected to repeat propofol treatment relative to vehicle. CONCLUSIONS: These data suggest that repeat propofol anesthesia may not exacerbate plaque deposition or associated synapse loss in AD. Interestingly, this data also provides some of the first evidence suggesting that repeat propofol exposure in adult wild-type mice does not result in robust long-term alterations in the levels of key excitatory and inhibitory synaptic markers.
29699479	7	15	propofol	Chemical	MESH:D015742
29699479	68	80	synapse loss	Disease	MESH:D016388
29699479	88	91	PS1	Gene	19164
29699479	92	111	Alzheimer's disease	Disease	MESH:D000544
29699479	112	116	mice	Species	10090
29699479	222	241	Alzheimer's disease	Disease	MESH:D000544
29699479	243	245	AD	Disease	MESH:D000544
29699479	309	314	human	Species	9606
29699479	379	381	AD	Disease	MESH:D000544
29699479	411	419	propofol	Chemical	MESH:D015742
29699479	423	425	AD	Disease	MESH:D000544
29699479	460	485	amyloid precursor protein	Gene	11820
29699479	486	498	presenilin 1	Gene	19164
29699479	504	507	PS1	Gene	19164
29699479	520	522	AD	Disease	MESH:D000544
29699479	523	527	mice	Species	10090
29699479	540	544	mice	Species	10090
29699479	572	580	propofol	Chemical	MESH:D015742
29699479	701	706	Abeta	Gene	11820
29699479	747	750	PS1	Gene	19164
29699479	751	755	mice	Species	10090
29699479	774	782	propofol	Chemical	MESH:D015742
29699479	853	865	synapse loss	Disease	MESH:D016388
29699479	873	876	PS1	Gene	19164
29699479	877	881	mice	Species	10090
29699479	899	907	propofol	Chemical	MESH:D015742
29699479	997	1029	post-synaptic density protein 95	Gene	13385
29699479	1031	1044	synaptophysin	Gene	20977
29699479	1111	1114	PS1	Gene	19164
29699479	1115	1119	mice	Species	10090
29699479	1140	1148	propofol	Chemical	MESH:D015742
29699479	1224	1232	propofol	Chemical	MESH:D015742
29699479	1295	1307	synapse loss	Disease	MESH:D016388
29699479	1311	1313	AD	Disease	MESH:D000544
29699479	1404	1412	propofol	Chemical	MESH:D015742
29699479	1441	1445	mice	Species	10090
29699479	Negative_Correlation	MESH:D015742	MESH:D000544

